Please use this identifier to cite or link to this item: doi:10.22028/D291-33038
Title: NLRP3 Is Involved in the Maintenance of Cerebral Pericytes
Author(s): Quan, Wenqiang
Luo, Qinghua
Tang, Qiqiang
Furihata, Tomomi
Li, Dong
Fassbender, Klaus
Liu, Alex Yang
Language: English
Title: Frontiers in Cellular Neuroscience
Volume: 14
Publisher/Platform: Frontiers
Year of Publication: 2020
Free key words: Alzheimer’s disease
neuroinflammation
NLRP3
pericyte
cerebral perfusion
DDC notations: 610 Medicine and health
Publikation type: Journal Article
Abstract: Pericytes play a central role in regulating the structure and function of capillaries in the brain. However, molecular mechanisms that drive pericyte proliferation and differentiation are unclear. In our study, we immunostained NACHT, LRR and PYD domains-containing protein 3 (NLRP3)-deficient and wild-type littermate mice and observed that NLRP3 deficiency reduced platelet-derived growth factor receptor β (PDGFRβ)-positive pericytes and collagen type IV immunoreactive vasculature in the brain. In Western blot analysis, PDGFRβ and CD13 proteins in isolated cerebral microvessels from the NLRP3-deficient mouse brain were decreased. We further treated cultured pericytes with NLRP3 inhibitor, MCC950, and demonstrated that NLRP3 inhibition attenuated cell proliferation but did not induce apoptosis. NLRP3 inhibition also decreased protein levels of PDGFRβ and CD13 in cultured pericytes. On the contrary, treatments with IL-1β, the major product of NLRP3-contained inflammasome, increased protein levels of PDGFRβ, and CD13 in cultured cells. The alteration of PDGFRβ and CD13 protein levels were correlated with the phosphorylation of AKT. Inhibition of AKT reduced both protein markers and abolished the effect of IL-1β activation in cultured pericytes. Thus, NLRP3 activation might be essential to maintain pericytes in the healthy brain through phosphorylating AKT. The potential adverse effects on the cerebral vascular pericytes should be considered in clinical therapies with NLRP3 inhibitors.
DOI of the first publication: 10.3389/fncel.2020.00276
Link to this record: urn:nbn:de:bsz:291--ds-330384
hdl:20.500.11880/30359
http://dx.doi.org/10.22028/D291-33038
ISSN: 1662-5102
Date of registration: 11-Jan-2021
Faculty: M - Medizinische Fakultät
Department: M - Neurologie und Psychiatrie
Professorship: M - Prof. Dr. Klaus Faßbender
Collections:SciDok - Der Wissenschaftsserver der Universität des Saarlandes

Files for this record:
File Description SizeFormat 
fncel-14-00276.pdfNLRP3 Is Involved in the Maintenance of Cerebral Pericytes3,19 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons